Guidelines on Methods for Measurement of Health Utilities

Going Global in Pharma: Understanding Preferred Health Technology Assessment (HTA) Utility Measures by Country

Are you up to date with HTA recommendations on health utility measurement for your cost utility model? Many HTA agencies make specific statements about their preferences for health utility measures, but their guidelines change over time. And it can be hard to find the right document. 

We maintain a summary table of up-to-date Health Technology Assessment authority guidelines across multiple countries on measurement methods for health utility weights.  You can download a pdf of our concise, timesaving table by filling out the brief form. 

If you need more, our integrated team of experts can help you with your utility measurement needs:
• Utility research design (trials, observational studies, surveys)
• Instrument/method selection
• Study implementation
• Cost utility data analyses
• Data incorporation into cost utility models

Summary table includes guidance for these countries:
Australia Pharmaceutical Benefits Advisory Committee (PBAC)
Brazil Health Technology Assessment General Coordination  (CGATS)
Canada Canadian Agency for Drugs and Technologies in Health (CADTH)
China No policy-generating agency
France French National Authority for Health (HAS)
Germany Institute for Quality and Economic Efficiency in Health Care (IQWiG)
Italy The Italian Medicines Agency (AIFA)
Mexico National Center for Health Technology Excellence (CENETEC)
Netherlands The National Health Care Institute (ZIN)
Norway Norwegian Medicines Agency (NoMA)
South Korea Health Insurance Review and Assessment Service (HIRA)
Spain Spanish Network of HTA
Sweden Dental and Pharmaceutical Benefits Agency (TLV)
USA Institute for Clinical and Economic Review (ICER)
UK National Institute for Health and Care Excellence (NICE)

 

 

 

 

 

 

 

 

 

 

 

 

 

Identifies preferred instruments/methods, including: Visual Analogue Scale (VAS) • Time Trade-Off (TTO) • Standard Gamble (SG) • Discrete Choice Experiments (DCE) •  EQ-5D  • Cross-walk  • HUI  •QWB  • SF-6D  • 15D  • AQoL

 

 

Submit
#e08226